P1048: PHARMACOKINETIC AND PHARMACODYNAMIC EFFECTS OF RUSFERTIDE IN POLYCYTHEMIA VERA: RESULTS FROM AN ONGOING PHASE 2 STUDY IN PATIENTS WITH ELEVATED HEMATOCRIT VALUES

Lignende værker

• P1048: PHARMACOKINETIC AND PHARMACODYNAMIC EFFECTS OF RUSFERTIDE IN POLYCYTHEMIA VERA: RESULTS FROM AN ONGOING PHASE 2 STUDY IN PATIENTS WITH ELEVATED HEMATOCRIT VALUES
  af: Marina Kremyanskaya, et al.
  Udgivet: (2023-08-01)
• Oestrogene mimetic isoflavones’ pharmacokinetics and pharmacodynamics
  af: Anca Dragomirescu,, et al.
  Udgivet: (2008-12-01)
• P1016: RUSFERTIDE (PTG-300) IMPROVES POLYCYTHEMIA VERA (PV) RELATED SYMPTOMS IN PV PATIENTS
  af: Andrew Kuykendall, et al.
  Udgivet: (2023-08-01)
• Comparison of the pharmacokinetic and pharmacodynamic properties of two recombinant granulocyte colony-stimulating factor formulations after single subcutaneous administration to healthy volunteers
  af: Audrius Sveikata, et al.
  Udgivet: (2014-01-01)
• Safety, pharmacokinetics and pharmacodynamics of Plozasiran in Chinese healthy volunteers
  af: Fangfang Wang, et al.
  Udgivet: (2025-10-01)